FOLD Historical Earnings image   This FOLD historical earnings page last updated 8/8/2022
FOLD Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20220.08B
Q1 20225/9/20220.08B
Q4 20212/24/20220.08B
Q3 202111/9/20210.08B
Q2 20218/5/20210.08B
Q1 20215/10/20210.07B
Q4 20203/1/20210.07B
Q3 202011/5/20200.07B
Q2 20208/10/20200.06B
Q1 20205/7/20200.06B
Q4 20193/2/20200.06B
Q3 201911/11/20190.05B
Q2 20198/8/20190.04B
Q1 20195/8/20190.03B
Q4 20182/28/201932.64M
Q3 201811/5/201820.60M
Q2 20188/7/201821.31M
Q1 20185/8/201816.70M
Q4 20172/28/201814.73M
Q3 201711/8/201710.87M
Q2 20178/7/20177.16M
Q1 20175/9/20174.17M
Q4 20163/1/20172.83M
Q3 201611/7/20162.13M
Q2 20168/9/2016NA
Q1 20165/3/2016NA
Q4 20152/26/2016NA
Q3 201511/3/2015NA
Q2 20158/5/2015NA
Q1 20155/5/2015NA
Q4 20143/3/2015NA
Q3 201411/6/2014293000
Q2 20148/7/2014475000
Q1 20145/5/2014456000
Q4 20133/3/20140.00B
Q3 201311/12/20130.04M
Q2 20138/7/2013NA
Q1 20135/9/2013NA
Q4 20123/12/2013NA
FOLD Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/4/2022-0.210
Q1 20225/9/2022-0.300
Q4 20212/24/2022-0.290
Q3 202111/9/2021-0.190
Q2 20218/5/2021-0.190
Q1 20215/10/2021-0.250
Q4 20203/1/2021-0.270
Q3 202011/5/2020-0.220
Q2 20208/10/2020-0.200
Q1 20205/7/2020-0.350
Q4 20193/2/2020-0.350
Q3 201911/11/2019-0.240
Q2 20198/8/2019-0.360
Q1 20195/8/2019-0.390
Q4 20182/28/2019-0.41
Q3 201811/5/2018-0.31
Q2 20188/7/2018-0.33
Q1 20185/8/2018-0.28
Q4 20172/28/2018-0.41
Q3 201711/8/2017-0.41
Q2 20178/7/2017-0.34
Q1 20175/9/2017-0.39
Q4 20163/1/2017-0.42
Q3 201611/7/2016-0.33
Q2 20168/9/2016-0.4
Q1 20165/3/2016-0.35
Q4 20152/26/2016-0.35
Q3 201511/3/2015-0.32
Q2 20158/5/2015-0.27
Q1 20155/5/2015-0.25
Q4 20143/3/2015-0.24
Q3 201411/6/2014-0.22
Q2 20148/7/2014-0.22
Q1 20145/5/2014-0.25
Q4 20133/3/2014-0.22
Q3 201311/12/2013-0.29
Q2 20138/7/2013-0.31
Q1 20135/9/2013-0.35
Q4 20123/12/2013-0.2
Quotes delayed 20 minutes

Email EnvelopeFree FOLD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Amicus Therapeutics (FOLD) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

FONR Historical Earnings
FREQ Historical Earnings
FSTX Historical Earnings
FULC Historical Earnings
FVE Historical Earnings
FWBI Historical Earnings
GALT Historical Earnings
GBIO Historical Earnings
GBT Historical Earnings
GEG Historical Earnings
What was the record high FOLD historical earnings result?
In terms of earnings or revenue, what is the best FOLD historical earnings result that Amicus Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest FOLD historical earnings result was set in Q3 2021, when Amicus Therapeutics posted results of -0.190/share. The most successful revenue quarter within our data set was Q4 2021 when Amicus Therapeutics reported revenue of 0.08B.

What was the lowest Amicus Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest FOLD has reported, and when?

✔️Accepted answer: Within our data set, the lowest FOLD historical earnings result was set in Q4 2016, when Amicus Therapeutics posted results of -0.42/share. The smallest revenue quarter within our data set was Q2 2016 when Amicus Therapeutics reported revenue of NA.

On this page we presented the FOLD historical earnings date information for Amicus Therapeutics. Reviewing that FOLD Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2021, when FOLD posted gaap of -0.190/share. Meanwhile the lowest FOLD historical earnings result was in Q4 2016, when FOLD posted gaap of -0.42/share. Moving to Amicus Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2021 when FOLD reported 0.08B in revenue, while the smallest revenue quarter was Q2 2016 when FOLD reported NA in revenue.

For self directed investors doing their due diligence on FOLD or any other given stock, their research can benefit from looking into all of the Amicus Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Amicus Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for FOLD. Thanks for visiting, and the next time you need to research FOLD historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: NNUP Insider Buying, Institutional Holders of XFP, NATH market cap history.

 

FOLD Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.